The future of biomarker driven therapies looks promising with ongoing research and technological advancements. Artificial Intelligence and machine learning are expected to play significant roles in analyzing complex biological data, leading to the discovery of new biomarkers and the development of more effective therapies. Additionally, initiatives like The Cancer Genome Atlas are expanding our understanding of cancer genomics, paving the way for more personalized treatment approaches.
